Growing Global - Strengthening life sciences supply chains

Life sciences organisations are stepping into a new phase of global growth - expanding into new markets, adapting to shifting demand, and navigating increasing complexity, all while trying to keep innovation moving at pace.

Overview

Global growth in the life sciences sector is no longer just a question of where to expand, but how to do so in a more demanding, less predictable environment. Supply chains, once optimised for efficiency, are now being redesigned for resilience, visibility, and control.

Businesses in the sector are rethinking how products are sourced, manufactured, and distributed to improve resilience, meet regulatory requirements, and ensure consistent access across regions.

Our latest report for pharma and life sciences explores how businesses in the sector are responding to this shift – reshaping where they operate, how they structure their networks, and what capabilities they need to grow sustainability.

Download the report

 

Key findings from the report

life sciences companies.png

 

of life sciences companies report no plans to expand internationally in next 5 years.

executives.png

 

of executives continue to express confidence in managing tariff driven costs, despite disruption linked to global trade. 

life sciences leaders.png

 

of life sciences leaders say localisation of drugs and therapies is the top barrier to international expansion.

Nigel Layton

“In life sciences, supply chains have to support regulatory compliance, product localisation and availability at the same time. That combination significantly increases the complexity of international expansion.”

Nigel Layton Partner - Head of Pharma & Life Sciences

Key contacts